DLEC1 expression could be restored with demethylating agents when downregulated, as demonstrated in lung, prostate, oral, nasopharyngeal, renal, ovarian, adrenocortical, and uterine tumors [11, 22, 25, 31, 53, 60–62, 65]. Here, DLEC1 is linked to tumor of uterus.